 |
PDBsum entry 5e2t
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
5e2t
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proteins
84:427-434
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8.
|
|
T.J.Malia,
A.Teplyakov,
R.Ernst,
S.J.Wu,
E.R.Lacy,
X.Liu,
M.Vandermeeren,
M.Mercken,
J.Luo,
R.W.Sweet,
G.L.Gilliland.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Microtubule-associated protein tau becomes abnormally phosphorylated in
Alzheimer's disease and other tauopathies and forms aggregates of paired helical
filaments (PHF-tau). AT8 is a PHF-tau-specific monoclonal antibody that is a
commonly used marker of neuropathology because of its recognition of abnormally
phosphorylated tau. Previous reports described the AT8 epitope to include
pS202/pT205. Our studies support and extend previous findings by also
identifying pS208 as part of the binding epitope. We characterized the
phosphoepitope of AT8 through both peptide binding studies and costructures with
phosphopeptides. From the cocrystal structure of AT8 Fab with the
diphosphorylated (pS202/pT205) peptide, it appeared that an additional
phosphorylation at S208 would also be accommodated by AT8. Phosphopeptide
binding studies showed that AT8 bound to the triply phosphorylated tau peptide
(pS202/pT205/pS208) 30-fold stronger than to the pS202/pT205 peptide, supporting
the role of pS208 in AT8 recognition. We also show that the binding kinetics of
the triply phosphorylated peptide pS202/pT205/pS208 was remarkably similar to
that of PHF-tau. The costructure of AT8 Fab with a pS202/pT205/pS208 peptide
shows that the interaction interface involves all six CDRs and tau residues
202-209. All three phosphorylation sites are recognized by AT8, with pT205
acting as the anchor. Crystallization of the Fab/peptide complex under acidic
conditions shows that CDR-L2 is prone to unfolding and precludes peptide
binding, and may suggest a general instability in the antibody. Proteins 2016;
84:427-434. © 2016 The Authors. Proteins: Structure, Function, and
Bioinformatics Published by Wiley Periodicals, Inc.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|